These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2599615)

  • 1. Susceptibility of clinical isolates to cephalexin, cefazolin and cefotaxime.
    Gupta BL; Tahlan A; Dogra V; Rattan A; Bhujwala RA; Shriniwas
    Indian Pediatr; 1989 May; 26(5):466-71. PubMed ID: 2599615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates.
    Anand AR; Therese KL; Madhavan HN
    Indian J Ophthalmol; 2000 Jun; 48(2):123-8. PubMed ID: 11116508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of clinical isolates of gram-positive and gram-negative organisms to cefatrizine.
    Carlone NA; Cuffini AM; Forno Pizzoglio M; Cavallo G
    Drugs Exp Clin Res; 1985; 11(7):447-51. PubMed ID: 3836867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparative activity of kanamycin, gentamicin and sisomicin--a new aminoglycoside, against clinical isolates.
    Lakshmi N; Kumar AG
    Indian J Pathol Microbiol; 1989 Jul; 32(3):207-12. PubMed ID: 2777351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotaxime: clinical and bacteriologic evaluation.
    Saroglou G; Paniara-Volika O; Sima A; Koltsida K; Rokas S; Kontomichalou P
    Clin Ther; 1981; 4(3):201-11. PubMed ID: 6272994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
    Ravizzola G; Bonfanti C; Savoldi E; Turano A
    Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro activity of new cephalosporin derivatives containing a benzoxazolone ring.
    Kalcheva V; Mincheva Z; Andreeva P
    Arzneimittelforschung; 1990 Sep; 40(9):1030-4. PubMed ID: 2080938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro fluoroquinolone resistance in ocular bacterial isolates].
    Sun XG; Wang ZQ; Li R; Chen L; Jin XY; Luo SY
    Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM; Turnidge JD;
    Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteraemia in a tertiary care urban hospital in south India.
    Chaudhury A; Rao TV
    Indian J Pathol Microbiol; 1999 Jul; 42(3):317-20. PubMed ID: 10862291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution and drug-resistance of 345 strains gram-negative bacilli from hospitalized patients with lower respiratory tract infections diseases].
    Li Y; Zhao Y; Wang K
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):588-9. PubMed ID: 11477872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.
    Briscoe D; Rubowitz A; Assia E
    Orbit; 2005 Mar; 24(1):29-32. PubMed ID: 15764113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing face of septicaemia and increasing drug resistance in blood isolates.
    Kumar S; Rizvi M; Vidhani S; Sharma VK
    Indian J Pathol Microbiol; 2004 Jul; 47(3):441-6. PubMed ID: 16295453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of bacteria isolated from cats with ulcerative keratitis in Taiwan.
    Lin CT; Petersen-Jones SM
    J Small Anim Pract; 2008 Feb; 49(2):80-3. PubMed ID: 17850276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000.
    Mamishi S; Pourakbari B; Ashtiani MH; Hashemi FB
    Int J Antimicrob Agents; 2005 Nov; 26(5):373-9. PubMed ID: 16213124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections.
    Gimeno C; Borja J; Navarro D; Valdés L; García-Barbal J; García-de-Lomas J
    Chemotherapy; 1998; 44(2):94-8. PubMed ID: 9551238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].
    Bertrand X; Costa Y; Pina P
    Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.